HK Stock Market Move | LIFETECH SCI (01302) Rises Over 4% in Morning Session; Absorbable Peripheral Balloon-Expandable Covered Stent System Enters Innovative Medical Management Device Special Review Procedure

LIFETECH SCI (01302) rose over 4% in the morning session. As of press time, it was up 4.08% at HK$1.53, with a turnover of HK$29.0531 million. On the news front, LIFETECH SCI announced that the company has received an official written notice from the National Medical Products Administration, confirming that the ICS Elpis Absorbable Peripheral Balloon-Expandable Covered Stent System, independently developed by the company's subsidiary Yuanxin Technology (Shenzhen) Co., Ltd., has entered the NMPA's Innovative Medical Management Device Special Review Procedure. The product is indicated for the treatment of atherosclerotic stenosis or occlusive lesions of the common iliac artery and external iliac artery, and is the company's 20th product to enter this NMPA procedure.